UnitedHealth Group (NYSE:UNH) PT Lowered to $603.00

UnitedHealth Group (NYSE:UNH) had its price target decreased by stock analysts at Barclays from $604.00 to $603.00 in a report released on Tuesday, Benzinga reports. The firm presently has an “overweight” rating on the healthcare conglomerate’s stock. Barclays‘s price target indicates a potential upside of 6.82% from the company’s previous close.

Several other equities analysts also recently weighed in on UNH. Robert W. Baird lifted their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Wells Fargo & Company increased their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday, October 16th. Finally, Cantor Fitzgerald upped their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Trading Down 0.9 %

NYSE UNH opened at $564.48 on Tuesday. The stock has a market capitalization of $519.54 billion, a price-to-earnings ratio of 34.50, a PEG ratio of 1.67 and a beta of 0.58. The business’s fifty day moving average is $584.16 and its 200-day moving average is $536.49. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group has a one year low of $436.38 and a one year high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same quarter last year, the business posted $6.56 EPS. UnitedHealth Group’s quarterly revenue was up 9.2% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group will post 27.61 EPS for the current year.

Institutional Trading of UnitedHealth Group

Hedge funds have recently added to or reduced their stakes in the business. Mirae Asset Global Investments Co. Ltd. lifted its position in UnitedHealth Group by 20.3% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 103,678 shares of the healthcare conglomerate’s stock valued at $57,131,000 after purchasing an additional 17,460 shares during the last quarter. BKM Wealth Management LLC boosted its position in UnitedHealth Group by 10.3% during the 3rd quarter. BKM Wealth Management LLC now owns 5,473 shares of the healthcare conglomerate’s stock valued at $3,200,000 after buying an additional 512 shares during the period. Allworth Financial LP increased its position in shares of UnitedHealth Group by 2.7% in the third quarter. Allworth Financial LP now owns 70,474 shares of the healthcare conglomerate’s stock valued at $41,205,000 after acquiring an additional 1,854 shares during the period. CWC Advisors LLC. purchased a new stake in shares of UnitedHealth Group during the third quarter worth about $1,078,000. Finally, Mayfair Advisory Group LLC bought a new position in UnitedHealth Group during the 3rd quarter valued at approximately $203,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.